Skip to main content

Table 2 Statistical analysis of five galectins expression versus clinicopathological data

From: Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications

Clinical data p value
  LGALS1 LGALS3 LGALS4 LGALS8 LGALS9
Age 0.587 0.439 0.890 0.360 0.412
parity 0.332 0.005 0.005 0.519 0.469
menarche 0.747 0.543 0.074 0.625 0.367
BMI 0.299 0.325 0.363 0.146 0.161
Menopause 0.948 0.281 1 0.662 0.261
Medical comorbidities 0.005 0.206 0.008 0.015 0.071
Surgical comorbidities 0.332 0.005 0.005 0.519 0.469
ca125 0.126 0.39 0.115 0.425 0.490
CEA 0.846 0.438 0.484 0.677 0.623
AFP 0.377 0.591 0.374 0.394 0.378
ca19.9 0.757 0.431 0.039 0.481 0.672
Organ metastasis 0.414 0.818 0.206 0.591 0.396
lymph node metastasis 0.228 0.044 0.088 0.178 0.013
FIGO STAGING 0.002 0.575 0.426 0.156 0.002
Cytology 0.060 0.777 0.416 0.922 0.912